Overcoming negatively charged tissue barriers: Drug delivery using cationic peptides and proteins

A Vedadghavami, C Zhang, AG Bajpayee - Nano today, 2020 - Elsevier
Negatively charged tissues are ubiquitous in the human body and are associated with a
number of common diseases yet remain an outstanding challenge for targeted drug delivery …

Recent advances in targeted drug delivery for treatment of osteoarthritis

S Mehta, T He, AG Bajpayee - Current opinion in rheumatology, 2021 - journals.lww.com
Recent years have witnessed significant increase in both fundamental and clinical studies
evaluating DDS for osteoarthritis. Steroid encapsulating polymeric microparticles for longer …

[HTML][HTML] Intra-articular nanoparticles based therapies for osteoarthritis and rheumatoid arthritis management

J Wen, H Li, H Dai, S Hua, X Long, H Li, S Ivanovski… - Materials Today Bio, 2023 - Elsevier
Osteoarthritis (OA) and rheumatoid arthritis (RA) are chronic and progressive inflammatory
joint diseases that affect a large population worldwide. Intra-articular administration of …

[HTML][HTML] Nanomaterial-assisted theranosis of bone diseases

K Zheng, J Bai, H Yang, Y Xu, G Pan, H Wang… - Bioactive Materials, 2023 - Elsevier
Bone-related diseases refer to a group of skeletal disorders that are characterized by bone
and cartilage destruction. Conventional approaches can regulate bone homeostasis to a …

[HTML][HTML] Peptide-based nanoparticles for therapeutic nucleic acid delivery

P Boisguérin, K Konate, E Josse, E Vivès, S Deshayes - Biomedicines, 2021 - mdpi.com
Gene therapy offers the possibility to skip, repair, or silence faulty genes or to stimulate the
immune system to fight against disease by delivering therapeutic nucleic acids (NAs) to a …

[HTML][HTML] Engineered nanoparticles as emerging gene/drug delivery systems targeting the nuclear factor-κB protein and related signaling pathways in cancer

R Eskandani, M Kazempour, R Farahzadi… - Biomedicine & …, 2022 - Elsevier
The transcription factor nuclear factor-κB (NF-κB) is a critical regulator of the immune
response, inflammation, cell growth, and survival. Canonical and non-canonical pathways …

Nanodevices for deep cartilage penetration

XL Xu, Y Xue, JY Ding, ZH Zhu, XC Wu, YJ Song… - Acta Biomaterialia, 2022 - Elsevier
Osteoarthritis (OA) is a degenerative joint disease and is the main cause of chronic pain and
functional disability in adults. Articular cartilage is a hydrated soft tissue that is composed of …

Targeted treatment for osteoarthritis: drugs and delivery system

L Mao, W Wu, M Wang, J Guo, H Li, S Zhang, J Xu… - Drug …, 2021 - Taylor & Francis
The management of osteoarthritis (OA) is a clinical challenge due to the particular avascular,
dense, and occluded tissue structure. Despite numerous clinical reports and animal studies …

Bio-responsive and multi-modality imaging nanomedicine for osteoarthritis theranostics

S Xue, G Ruan, J Li, H Madry, C Zhang, C Ding - Biomaterials Science, 2023 - pubs.rsc.org
Osteoarthritis (OA) is one of the most common joint diseases currently, characterized by the
gradual degradation of cartilage, remodeling of subchondral bone, development of synovitis …

[HTML][HTML] Is extracellular vesicle-based therapy the next answer for cartilage regeneration?

E Velot, H Madry, JK Venkatesan, A Bianchi… - … in Bioengineering and …, 2021 - frontiersin.org
“Extracellular vesicles”(EVs) is a term gathering biological particles released from cells that
act as messengers for cell-to-cell communication. Like cells, EVs have a membrane with a …